Specifically, the activated monocyte/macrophage-associated markers IL-1β and CXCL16 were declined post-treatment, highlighting the potential of Stem Cell Educator therapy for the clinical management of patients with Crohn’s disease. The gene discussed is CXCL16; the disease is Crohn disease.